The Chumakov Center is preparing a version of the coronavirus vaccine against the delta strain, which can be made in the form of a combined vaccine, said Aidar Ishmukhametov, the director of the center.
“Yes, absolutely … we have already isolated the delta strain, and we are doing all the preparatory steps to make a new vaccine. It is not about updating our existing vaccine, it would be a little bit wrong to say that, <…> instead of the alpha variant, this vaccine will contain the delta variant,” Ishmukhametov said on Rossiya-24 TV channel.
According to him, the new vaccine may contain two components.
“We are now working on these things, it can be a combination or a complex vaccine … Of course, these are two components of the same vaccine, otherwise there would be no sense, it would be two different vaccines, ” Interfax reports Ishmukhametov’s statement.
The head of the Chumakov Center urged residents of the Russian Federation not to expect the emergence of new drugs and to get vaccinated with already registered ones.
The Chumakov Center has already developed an anti-COVID-19 vaccine CoviVac, which is a whole-virion vaccine. Like most coronavirus vaccines in use, it consists of two components. The drug was registered in Russia on February 19, 2021.